SINGAPORE, March 30, 2020 /PRNewswire/ -- Novena Global Lifecare (the "Company" or "NGL"), entrenches its footprint in Singapore for its medical healthcare division under its group of companies, Novena Global Surgery. As one of Asia's largest integrated medical healthcare and aesthetics group, Novena Global Lifecare has established itself as leader in Taiwan's health screening sector.
Currently, Novena Global Lifecare drives a multi-million revenue portfolio that provides lifecare management solutions tailored to Asian demographics to help customers in their journey of well-being across their life stages. The establishment of Novena Global Surgery includes Aptus Surgery Centre ("Aptus") in Paragon Medical Centre and Novaptus Surgery Centre ("Novaptus") at Camden Medical Centre. Both offer health screenings and day surgery facilities to their customers.
Terence Loh, co-founder of NGL, said: "Our move to drive our focus in expanding our Medical Healthcare services division back in Singapore is timely. Despite such a challenging time for businesses, we still believe the focus on healthcare is now ever important. Singapore ranks high in medical inflation prospects in the region. NGL's ethos of providing value to its clients coupled with our expertise especially in Taiwan, will allow us to champion shifts in driving affordable primary healthcare services for all. Day surgery centres are known to be more cost-effective as it helps patients save up to 20 - 30% in medical fees and time efficacy in today's escalating healthcare costs."
Each of its facilities have four state-of-the-art operating theatres with cableless pendant systems and are equipped for a range of surgeries, including plastic, dental and eye procedures rivalling. Patients are also able to have hand, laparoscopic surgery and endoscopic diagnostic procedures carried out.
Nelson Loh, chairman and co-founder, Novena Global Lifecare, says, "I am especially proud to mark our expansion into Novena Global Surgery in addition, to being officiated as a preferred partner for ambulatory services with AIA insurance. It accredits us with the stamp of approval for our facilities which are one of the foremost in Singapore."
The official signing ceremony was held on 27 March 2020 and was presided by Novena Global Lifecare Co-Founders, Mr Nelson Loh (Executive Chairman) & Mr Terence Loh (CEO); Dr Lim Cheok Peng, Senior Medical Advisor of Novena Global Healthcare group; and Ms Melita Teo, Chief Operations Officer of AIA Singapore whom officiated the partnership.
Another venture that Novena Global Surgery facilities also allows is the exclusivity and unparalleled service in their Health screening services. With its hassle free admissions, its centres allows care to only an exclusive few and shortens waiting time for a patient.
In such critical times with the recent pandemic, there has not been a more pressing time to compel one to take steps to ensure preventive measures are taken to ensure that they are in the best of health. With its success in their health screening division in Taiwan, Novena Global Lifecare hopes to extend its expertise to Singapore via its facilities at Paragon and Camden
"Novena Global Surgery looks to expand its foray to the growing corporate and private healthcare screening market and take the initiative to enhance preventive care services in our offerings," adds Nelson Loh. "Preventive care is key in every patient's health journey. As the importance of 'Self-care' is popularised and in our current situation for everyone to be more vigilant to be in the best of health, we hope to drive unique customised packages to encourage continuity and cater for a holistic medical wellness journey especially for Active Male individuals seeking more than just a screening."
Dr Lim Beng Hai, Chairman of the board of directors of Novaptus and Aptus Surgery Centres and as the new Medical Director of Novena Global Surgery, the NGL subsidiary which the two centres will be parked under, said: "I am excited over plans to grow Novena Global Surgery to new heights islandwide. With NGL's expertise in A.I Technology, we hope to be able to create new levels of experience and yet strive to offer premier affordable Ambulatory Care Centres in Singapore and in time, around the region."
For media queries, please contact:
Associate Director, Marketing,
Novena Global Lifecare
Phone: +65 6252 1750
Email: [email protected]
Novena Global Surgery (Aptus Pte Ltd and Novaptus Pte Ltd)
Aptus and Novaptus are premier but affordable day surgery centres in Singapore with state-of-the-art equipment and facilities dedicated for surgeries in Orthopaedics, Hand, ENT, Gynaecology, Urology, Plastic, Oral Surgery, Ophthalmology, Gastroscopy and Colonoscopy. The design configuration of the centres are focused on efficient use of space to maximise efficient nursing care, and private suites and recovery rooms with excellent monitoring equipment provide maximum comfort for patients. Each centre has a professional administration system for easy scheduling of surgeries, efficient and quick turnarounds with minimal delay.
Novaptus has a dedicated state of the art operating facilities for eye surgery. This allows for complex eye surgeries, such as vitrectomy and cornea transplants to be done there safely in addition to the less complex ones like cataract surgeries. Health Screening services are also available to provide a one-stop solution for patients.
About Novena Global Lifecare
Novena Global Lifecare (NGL) is one of the largest integrated medical healthcare and aesthetic groups regionally with presence in Singapore, Mainland China, Hong Kong, South Korea, Taiwan, Indonesia, India and Malaysia.
Founded in 2010 by former investment bankers and cousins Terence and Nelson Loh, the group's network is now in 250 locations in over 20 cities and drives a multi-million revenue portfolio that provides lifecare management solutions tailored to Asian demographics to help customers in their journey of well-being across their life stages.
NGL has established a track record of more than 8 million procedures performed worldwide and over 2 million patients in its Pan Asian patient database. Founded in 2016, NGL is the first medical aesthetics group in the world to integrate in-house medical equipment manufacturing, CRM data analytics, and research and development and sells its line of skincare products in some 1,000 points of sale in the world. NGL's subsidiary, Novena Life Sciences is the largest enterprise health screening provider in Taiwan which carries out corporate health screenings: under the brands of Bolian Biotech and Lianwei Biotech.
SOURCE Novena Global Lifecare